Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD

This is a Phase III clinical trial testing a drug called Buagafuran capsules — a new medication being studied for generalized anxiety disorder (GAD), a condition involving persistent, hard-to-control worry — to see if it is effective and safe compared to a placebo. **You may be eligible if...** - You are between 18 and 65 years old - You have been diagnosed with generalized anxiety disorder (GAD) according to established psychiatric criteria - Your anxiety is significant enough to require medication (anxiety scale score of 20 or higher) - You are an outpatient (not currently hospitalized) - You are able to give informed consent and attend follow-up visits **You may NOT be eligible if...** - You have significant depression alongside your anxiety (depression scale above 17) - You have active thoughts of suicide or a high suicide risk score - Your anxiety symptoms improved significantly between your screening and baseline visit (may indicate natural recovery) - You are currently participating in another drug trial - You have serious physical health conditions affecting heart, liver, or kidneys Talk to your doctor to see if this trial is right for you.